Results Per Page:

Now showing items 1-100 of 29

Acrosome reaction (1)
Alkylating agents (1)
Annexin V-cy3 (1)
Annexin V-Cy3 fluorescent staining (1)
Antagonism (1)
Anti-cancer agents (1)
Anti-cancer drug (1)
Antineoplastic (1)
Apocynaceae (1)
Apoptosis (29)
Autophagy (2)
Bi-conjugation (1)
Bio-assay guided fractionation (1)
Biomarkers (1)
Brain tumours (1)
Breast cancer (4)
Calcium influx (1)
Cancer (4)
Cancer specific peptides (1)
Capacitation (1)
Cardiomyocytes (2)
Caspases (1)
CD4 (Cluster of differentiation 4) (1)
Cell cycle (1)
Cell death (2)
Cellular (2)
Chemoprevention (1)
Chemotherapy (1)
Cisplatin (2)
Cissampelos capensis (1)
Cytology (1)
Cytoprotection (2)
Cytotoxicity (5)
DNA damage (1)
DNA fragmentation (2)
Dose-reduction indices (1)
Dose-response curves (1)
Doxorubicin (1)
Drug combination analysis (1)
Drug design (1)
Drug repurposing (1)
EDC (1)
EGFR gene expression analysis (1)
EGFR inhibitor I (1)
EGFR inhibitor II/BIBX1382 (1)
EGFR/ErbB2/ErbB4 inhibitor (1)
Electrophoretic mobility shift assay (1)
Endoplasmic reticulum (1)
Endoplasmic reticulum stress (1)
Epidermal growth factor receptor (1)
Eurycoma longifolia Jack (Tongkat Ali) (1)
Excitotoxicity (2)
Flow cytometry (1)
Fluorescence (1)
Fura-2 AM (1)
Germ cells (1)
Glioblastoma (1)
Gold nanorods (1)
Gold(I) complexes (1)
Haematoxylin and eosin staining (1)
Heat shock proteins (1)
Heat shock response (1)
HIV-1 (Human Immunodeficiency Virus Type 1) (1)
Homologous recombination (1)
Human MCF-7 breast carcinoma cells (1)
IC50/EC50 (1)
Inducible gene expression (1)
Interference RNA (RNAi) (1)
Lipid peroxidation (1)
LNCaP cells (1)
Lung cancer (1)
Marine natural product (1)
Mitochondrial membrane potential (1)
Molecular chaperones (2)
Motility (1)
Multidrug resistance (1)
N-methyl-D-aspartate (NMDA) receptors (1)
N-methyl-D-aspartate receptor (1)
Nanomedicine (1)
Nanotechnology (3)
Natural Killer cells (1)
Natural products (2)
Necrosis (1)
Neurodegeneration (1)
Neurodegenerative Diseases (1)
Neurodegenerative diseases (1)
Neurodegenerative Diseases--drug therapy (1)
Neurodegenerative disorders (1)
Neuroprotection (2)
Neuroprotective agents (1)
Nicotine (1)
Nicotine and prostaglandin A2 (PGA2) (1)
Nitric oxide (1)
NO-donating (1)
Novel lead compound (1)
Oleanolic acid (OA) (1)
Oxidative damage (1)
Oxidative stress (1)
P-Glycoprotein (1)
p53 (1)